🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to characterize the single dose pharmacokineti...
Status
Completed
Location
PRA Health Sciences 2
Start Date
2021-11-16
Trial ID
NCT05112939
The purpose of this study is to evaluate the efficacy and safety of CABENUV...
Status
Completed
Location
Allegheny Health Network
Start Date
2023-01-01
Trial ID
NCT05601128
Treatments Being Tested
Context The introduction of the long-acting injectable antiretroviral treat...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-05
Trial ID
NCT06403865
Treatments Being Tested
The RELATIVITY study is a nationwide, multicenter, ambispective observation...
Status
Active Not Recruiting
Location
Hospital Universitario de Burgos
Start Date
2024-12-31
Trial ID
NCT07703748
The purpose of this pharmacokinetic (PK) trial is to evaluate whether the E...
Status
Withdrawn
Location
Multiple Locations
Start Date
2024-01-01
Trial ID
NCT05156658
Treatments Being Tested
The Antiretroviral Therapy as Long Acting Suppression (ATLAS) study is bein...
Status
Active Not Recruiting
Location
GSK Investigational Site
Start Date
2016-10-28
Trial ID
NCT02951052
This is a multicentre study carried out in participants living with human i...
Status
Completed
Location
GSK Investigational Site
Start Date
2023-07-06
Trial ID
NCT05917509
Treatments Being Tested
This study addresses real-world use of long-acting injectable cabotegravir/...
Status
Active Not Recruiting
Location
Yale Clinical and Community Research
Start Date
2024-08-01
Trial ID
NCT06411223
Treatments Being Tested
The overall objective of the CAB LA + RPV LA clinical development program i...
Status
Completed
Location
GSK Investigational Site
Start Date
2020-09-28
Trial ID
NCT04399551
Treatments Being Tested
This study compares the efficacy, safety and tolerability of CAB ULA and RP...
Status
Recruiting
Location
GSK Investigational Site
Start Date
2026-06-25
Trial ID
NCT07650916